Abstract
The use of biomarkers of microvascular structure and function from perfusion and permeability imaging is now well established in neuro-oncological research. There remain significant challenges to be overcome before these techniques and related biomarkers can find general clinical acceptance. Core to this is the standardization of acquisition and processing protocols for robust use across multiple clinical sites. The potential clinical benefits of these approaches are already becoming clear, particularly in the setting of novel antiangiogenic therapies. With an increasing body of evidence in the scientific literature, and with a steadily falling barrier to entry, the coming decade should see rapid developments in imaging biomarkers, and facilitate their transition into routine clinical practice.
Original language | English |
---|---|
Pages (from-to) | 337-53 |
Number of pages | 17 |
Journal | Neuroimaging clinics of North America |
Volume | 20 |
Issue number | 3 |
DOIs | |
Publication status | Published - Aug 2010 |
Keywords / Materials (for Non-textual outputs)
- Biomarkers, Tumor
- Brain
- Brain Neoplasms
- Capillary Permeability
- Contrast Media
- Diagnosis, Differential
- Glioma
- Humans
- Lymphoma
- Magnetic Resonance Angiography
- Magnetic Resonance Imaging
- Neovascularization, Pathologic
- Tomography, X-Ray Computed